Justin Hanes is a VenturePartner & the Chief Scientist at Catalio Capital Management, LP.
Director, Center of Nanomedicine at Johns Hopkins Medicine
Nanomedicine
EDUCATION
BS – University of California Los Angeles
PhD – Massachusetts Institute of Technology
AWARDS AND ACCOLADES
National Academy of Inventors
The World’s Most Influential Scientific Minds / Highly Cited Researcher” by Thompson Reuters
MIT Technology Review 35 Innovators Under 35
COMPANIES AND BOARDS
Co-Founder – Kala Pharmaceuticals (NASDAQ: KALA), GrayBug Vision, Ashvattha Therapeutics, Orpheris, Theraly Fibrosis, Neuraly, Spiral Therapeutics, Advanced Inhalation Research (acquired by Alkermes), Civitas Therapeutics (acquired by Acorda)
